Toxicity is typically monitored through clinical observation and, when necessary, blood tests to measure drug concentrations. Patients on long-term chloroquine or hydroxychloroquine therapy are advised to undergo regular ophthalmologic examinations to detect early signs of retinopathy. For drugs like mefloquine, patients should be monitored for any changes in mood or behavior.
